These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 30018118)
1. Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. Akiba T; Morikawa T; Odaka M; Nakada T; Kamiya N; Yamashita M; Yabe M; Inagaki T; Asano H; Mori S; Tsukamoto Y; Urashima M Clin Cancer Res; 2018 Sep; 24(17):4089-4097. PubMed ID: 30018118 [No Abstract] [Full Text] [Related]
2. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial. Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526 [TBL] [Abstract][Full Text] [Related]
3. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055 [TBL] [Abstract][Full Text] [Related]
4. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. Heist RS; Zhou W; Wang Z; Liu G; Neuberg D; Su L; Asomaning K; Hollis BW; Lynch TJ; Wain JC; Giovannucci E; Christiani DC J Clin Oncol; 2008 Dec; 26(34):5596-602. PubMed ID: 18936471 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Zhou W; Heist RS; Liu G; Neuberg DS; Asomaning K; Su L; Wain JC; Lynch TJ; Giovannucci E; Christiani DC Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2239-45. PubMed ID: 17119052 [TBL] [Abstract][Full Text] [Related]
6. Effect of Vitamin D on Relapse-Free Survival in a Subgroup of Patients with p53 Protein-Positive Digestive Tract Cancer: A Akutsu T; Okada S; Hirooka S; Ikegami M; Ohdaira H; Suzuki Y; Urashima M Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):406-413. PubMed ID: 31871108 [TBL] [Abstract][Full Text] [Related]
7. Genetic Variations in VDR could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double Blind Controlled Trial. Mohseni H; Amani R; Hosseini SA; Ekrami A; Ahmadzadeh A; Latifi SM Asian Pac J Cancer Prev; 2019 Jul; 20(7):2065-2072. PubMed ID: 31350967 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk. Wu X; Cheng J; Yang K Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis. Mimpen M; Rolf L; Poelmans G; van den Ouweland J; Hupperts R; Damoiseaux J; Smolders J PLoS One; 2021; 16(12):e0261097. PubMed ID: 34855907 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S; Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639 [TBL] [Abstract][Full Text] [Related]
11. Effect of Vitamin D Supplements on Relapse or Death in a p53-Immunoreactive Subgroup With Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial. Kanno K; Akutsu T; Ohdaira H; Suzuki Y; Urashima M JAMA Netw Open; 2023 Aug; 6(8):e2328886. PubMed ID: 37606927 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial. De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228 [TBL] [Abstract][Full Text] [Related]
13. Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812). Crew KD; Anderson GL; Hershman DL; Terry MB; Tehranifar P; Lew DL; Yee M; Brown EA; Kairouz SS; Kuwajerwala N; Bevers T; Doster JE; Zarwan C; Kruper L; Minasian LM; Ford L; Arun B; Neuhouser M; Goodman GE; Brown PH Cancer Prev Res (Phila); 2019 Jul; 12(7):481-490. PubMed ID: 31138522 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer. Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702 [TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers. de Medeiros Cavalcante IG; Silva AS; Costa MJ; Persuhn DC; Issa CT; de Luna Freire TL; da Conceição Rodrigues Gonçalves M Exp Gerontol; 2015 Jun; 66():10-6. PubMed ID: 25827670 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. Grau MV; Baron JA; Sandler RS; Haile RW; Beach ML; Church TR; Heber D J Natl Cancer Inst; 2003 Dec; 95(23):1765-71. PubMed ID: 14652238 [TBL] [Abstract][Full Text] [Related]
18. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer. Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169 [TBL] [Abstract][Full Text] [Related]
19. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women]. Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525 [TBL] [Abstract][Full Text] [Related]
20. Effect Modification of Vitamin D Supplementation by Histopathological Characteristics on Survival of Patients with Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial. Yonaga H; Okada S; Akutsu T; Ohdaira H; Suzuki Y; Urashima M Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]